Organogenesis (ORGO): CEO sold ~$213K
Gary S. Gillheeney, CEO at Organogenesis, sold ~$213K of Organogenesis shares.
- ~$213K
- Approx. value · 59K sh @ $3.64
- 3.3M
- Holds after · shares reported
- Traded
- Dec 10, 2024
- Filed
- Dec 13, 2024
What stands out in this filing
- The sale was 1.7% of the shares this insider held before it; the filing reports 3,301,201 shares afterwards.
- 58,525 shares at an average of $3.64 each, as reported on the form.
- Footnote references tax withholding.
Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Dec 6, 2024InsiderCEO sold ~$67K of ORGO shares in the open market
- Dec 9, 2024InsiderCEO sold ~$145K of ORGO shares in the open market
- Dec 10, 2024 · this disclosureInsiderCEO sold ~$213K of ORGO shares in the open market
What came next
- Dec 11, 2024InsiderCEO sold ~$573K of ORGO shares in the open market
- Dec 12, 2024InsiderCEO sold ~$154K of ORGO shares in the open market
- Dec 13, 2024InsiderCEO sold ~$187K of ORGO shares in the open market
- Dec 16, 2024InsiderCEO sold ~$19K of ORGO shares in the open market
- Mar 4, 2025InsiderDirector sold ~$128K of ORGO shares in the open market
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Organogenesis
For Organogenesis, OQRO holds 2 federal contract awards dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ORGO page.
Other recent filings by Gary S. Gillheeney, President and CEO
- SEC Form 4 at Organogenesis (ORGO)Dec 17, 2024
- SEC Form 4 at Organogenesis (ORGO)Dec 17, 2024
- SEC Form 4 at Organogenesis (ORGO)Dec 13, 2024
- SEC Form 4 at Organogenesis (ORGO)Dec 13, 2024
- SEC Form 4 at Organogenesis (ORGO)Dec 10, 2024
The full history of Gary S. Gillheeney, President and CEO is on the profile page.
How this filing works
Explore the data
Common questions
Which Organogenesis (ORGO) insider traded, and how much?
Gary S. Gillheeney, CEO at Organogenesis, sold ~$213K of Organogenesis shares. 59K shares at $3.64.
When did it happen, and when was it made public?
Traded: Dec 10, 2024. Filed: Dec 13, 2024. That is 3 days between the two dates.
What stands out in this filing?
The sale was 1.7% of the shares this insider held before it; the filing reports 3,301,201 shares afterwards. 58,525 shares at an average of $3.64 each, as reported on the form. Footnote references tax withholding.
Is the dollar amount exact?
It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.
Where does this information come from?
From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about Organogenesis recently?
For Organogenesis, OQRO holds 2 federal contract awards dated in the last 90 days. They are listed on the ORGO page.
Does this mean ORGO stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Organogenesis
- USAspending.gov award recordSep 17, 2026
- USAspending.gov award recordSep 17, 2026
- USAspending.gov award recordDec 25, 2025
- USAspending.gov award recordDec 18, 2025
- USAspending.gov award recordDec 18, 2025
- USAspending.gov award recordDec 18, 2025
Everything OQRO holds on this company is on its ORGO page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
